Codexis Inc.

2.02+0.0300+1.51%Vol 758.97K1Y Perf -69.38%
Oct 4th, 2023 16:00 DELAYED
BID1.93 ASK2.19
Open1.99 Previous Close1.99
Pre-Market- After-Market2.00
 - -  -0.02 -0.92%
Target Price
17.88 
Analyst Rating
Strong Buy 1.33
Potential %
785.15 
Finscreener Ranking
★★★★★     59.07
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★     55.38
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+     55.06
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
10.31 
Earnings Rating
Strong Sell
Market Cap141.00M 
Earnings Date
2nd Nov 2023
Alpha-0.03 Standard Deviation0.20
Beta1.72 

Today's Price Range

1.962.06

52W Range

1.456.98

5 Year PE Ratio Range

-57.60-38.90

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
28.39%
1 Month
10.56%
3 Months
-26.84%
6 Months
-49.87%
1 Year
-69.38%
3 Years
-82.99%
5 Years
-88.58%
10 Years
20.61%

TickerPriceChg.Chg.%
CDXS2.020.03001.51
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
4.30
4.60
0.20
0.29
-
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
72.60
-24.10
-17.00
-31.40
-19.39
RevenueValueIndustryS&P 500US Markets
108.22M
1.65
18.71
16.07
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.21-0.1719.05
Q01 2023-0.29-0.34-17.24
Q04 2022-0.23-0.1917.39
Q03 2022-0.18-0.1516.67
Q02 2022-0.14-0.0471.43
Q01 2022-0.18-0.1327.78
Q04 2021-0.18-0.1611.11
Q03 2021-0.090.03133.33
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.32-18.52Negative
12/2023 QR-0.19-5.56Negative
12/2023 FY-0.96-2.13Negative
12/2024 FY-0.6916.87Positive
Next Report Date2nd Nov 2023
Estimated EPS Next Report-0.32
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume758.97K
Shares Outstanding69.80K
Shares Float65.41M
Trades Count4.65K
Dollar Volume1.53M
Avg. Volume1.12M
Avg. Weekly Volume1.17M
Avg. Monthly Volume1.11M
Avg. Quarterly Volume1.07M

Codexis Inc. (NASDAQ: CDXS) stock closed at 1.99 per share at the end of the most recent trading day (a 0.51% change compared to the prior day closing price) with a volume of 810.15K shares and market capitalization of 141.00M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 161 people. Codexis Inc. CEO is John J. Nicols.

The one-year performance of Codexis Inc. stock is -69.38%, while year-to-date (YTD) performance is -57.3%. CDXS stock has a five-year performance of -88.58%. Its 52-week range is between 1.45 and 6.98, which gives CDXS stock a 52-week price range ratio of 10.31%

Codexis Inc. currently has a PE ratio of -11.20, a price-to-book (PB) ratio of 2.29, a price-to-sale (PS) ratio of 3.41, a price to cashflow ratio of 49.90, a PEG ratio of -, a ROA of -14.57%, a ROC of -16.15% and a ROE of -20.97%. The company’s profit margin is -19.39%, its EBITDA margin is -17.00%, and its revenue ttm is $108.22 Million , which makes it $1.65 revenue per share.

Of the last four earnings reports from Codexis Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.32 for the next earnings report. Codexis Inc.’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for Codexis Inc. is Strong Buy (1.33), with a target price of $17.88, which is +785.15% compared to the current price. The earnings rating for Codexis Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Codexis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Codexis Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.38, ATR14 : 0.15, CCI20 : 105.51, Chaikin Money Flow : 0.09, MACD : -0.05, Money Flow Index : 38.44, ROC : 2.58, RSI : 56.67, STOCH (14,3) : 76.06, STOCH RSI : 1.00, UO : 65.73, Williams %R : -23.94), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Codexis Inc. in the last 12-months were: Dilly Stephen (Buy at a value of $101 169), Dilly Stephen (Sold 55 075 shares of value $252 266 ), John J. .Nicols (Sold 0 shares of value $-422 139 ), John J. .Nicols (Sold 293 854 shares of value $1 468 954 ), John J. Nicols (Option Excercise at a value of $844 295), John J. Nicols (Sold 746 863 shares of value $4 149 846 ), Kevin Norrett (Buy at a value of $15 480), Kevin Norrett (Sold 16 854 shares of value $77 182 ), Margaret Nell Fitzgerald (Buy at a value of $20 118), Ryali Sriram (Buy at a value of $19 805), Stephen Dilly (Sold 55 075 shares of value $252 212 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
5 (83.33 %)
6 (85.71 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
1 (16.67 %)
1 (14.29 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.29

Codexis Inc.

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases etc. The company operates in two business segment namely Performance Enzymes and Novel Biotherapeutics.

CEO: John J. Nicols

Telephone: +1 650 421-8100

Address: 200 Penobscot Drive, Redwood City 94063, CA, US

Number of employees: 161

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

54%46%

Bearish Bullish

56%44%

 

TipRanks News for CDXS


News

Stocktwits